111 related articles for article (PubMed ID: 10412337)
1. Early homogeneously enhancing hemangioma versus hepatocellular carcinoma: differentiation using quantitative analysis of multiphasic dynamic magnetic resonance imaging.
Jeong MG; Yu JS; Kim KW; Jo BJ; Kim JK
Yonsei Med J; 1999 Jun; 40(3):248-55. PubMed ID: 10412337
[TBL] [Abstract][Full Text] [Related]
2. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
[TBL] [Abstract][Full Text] [Related]
4. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
5. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
8. MR differentiation of hepatocellular carcinoma from cavernous hemangioma: complementary roles of FLASH and T2 values.
Ohtomo K; Itai Y; Yoshida H; Kokubo T; Yoshikawa K; Iio M
AJR Am J Roentgenol; 1989 Mar; 152(3):505-7. PubMed ID: 2536997
[TBL] [Abstract][Full Text] [Related]
9. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
10. [Low flip-angle spin-echo imaging of the liver. Basic study and its application to hepatic space-occupying lesions].
Yasui K; Sugimura K
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Sep; 51(9):1017-26. PubMed ID: 1658732
[TBL] [Abstract][Full Text] [Related]
11. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.
Yoshida H; Itai Y; Ohtomo K; Kokubo T; Minami M; Yashiro N
Radiology; 1989 May; 171(2):339-42. PubMed ID: 2539606
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of 3DFT-FISP MR imaging in differential diagnosis of liver tumor].
Ishida T; Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Hashimoto T; Kozuka T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb; 54(2):101-8. PubMed ID: 8121775
[TBL] [Abstract][Full Text] [Related]
13. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
[TBL] [Abstract][Full Text] [Related]
14. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM
Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717
[TBL] [Abstract][Full Text] [Related]
15. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
18. Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T.
Choi BI; Han MC; Kim CW
Radiology; 1990 Jul; 176(1):103-6. PubMed ID: 2162066
[TBL] [Abstract][Full Text] [Related]
19. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
[TBL] [Abstract][Full Text] [Related]
20. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T.
Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B
J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
